Company / Working Capital
Vericel Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$198.3M
FY2025
5-year range
$132.4M / $198.3M
FY2021-FY2025
Trend
+22.0%
vs FY2024
Sector context
#172 of 213
Health Care
What the data says
Vericel's working capital of $198M is lower than 81% of companies in the Health Care sector (FY2025). Working Capital has increased for 6 consecutive years, from $92M in FY2019 to $198M in FY2025.
Based on SEC 10-K filings.
$198M in FY2025 with a 5-year CAGR of +14.4%.
Improved from $160M to $198M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +9.9%
- 5-Year CAGR
- +14.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 213This company $198.3M Sector average $934.6M
▼
-78.8% below sector average
Key checks
Key Insights
- Vericel's working capital has grown for 6 consecutive years.
- 5-year CAGR of +14.4%, indicating consistent growth.
- In FY2025, working capital increased 22.0% year-over-year.
- Ranks #172 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $198.3M | +22.0% |
| FY2024 | $162.5M | +1.6% |
| FY2023 | $159.9M | +7.0% |
| FY2022 | $149.4M | +12.8% |
| FY2021 | $132.4M | +31.0% |
| FY2020 | $101.1M | +10.0% |
| FY2019 | $91.9M | -6.3% |
| FY2018 | $98.0M | +161.9% |
| FY2017 | $37.4M | +17.4% |
| FY2016 | $31.9M | +109.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026